Purchase Order 75N91025P00384

This is a $14,500 firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI) to Labcorp Genetics Inc., a for-profit manufacturer of goods specializing in genetic testing and laboratory services. The contract is for genetic testing services, with a performance period from July 1, 2025 to June 30, 2026. The contract does not have a set-aside designation. Labcorp Genetics Inc. has secured multiple federal contract awards from agencies like NCI and the Veterans...

<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to Genus Biosystems Inc., a for-profit organization, for $23,520.00 to provide lab testing services. The contract has a completion date of November 1, 2024 and was awarded on May 1, 2024. The place of performance is Northbrook, IL 60062, USA. This contract award is not associated with any set-aside designation.</p>

The National Cancer Institute (NCI) awarded a $142,009.29 firm fixed-price purchase order contract to Fundacio Centre De Regulacio Genomica, a non-profit biomedical research institute, to perform targeted gene sequencing on samples collected by NCI's Division of Cancer Epidemiology and Genetics. This contract, which does not have a set-aside designation, is expected to be completed by June 2023. The contract was awarded in September 2021 under simplified acquisition procedures for commercial...

This firm-fixed-price purchase order was awarded by the National Human Genome Research Institute (NHGRI), a civilian federal agency, to Laboratory Corporation of America (LabCorp) for the provision of noninvasive prenatal testing (NIPT) services. The contract, which does not have a set-aside designation, has a ceiling value of $24,950.00 and an ultimate completion date of September 30, 2024. LabCorp, a leading global life sciences company, is the prime contractor and will deliver a range of...

<p>This firm-fixed-price purchase order was awarded by the National Cancer Institute, a civilian federal agency, to Abiosciences Inc. for $14,000.00 to provide lab testing services. The award has an ultimate completion date of October 25, 2024 and was made on June 26, 2024. No set-aside designation is mentioned. The contract does not appear to be associated with a larger vehicle.</p>

The National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, awarded a $14,225 firm fixed-price purchase order contract to N-Of-One, Inc., a self-certified small disadvantaged business, for laboratory testing services. This is the fifth prime federal contract awarded to N-Of-One by the National Cancer Institute between 2019 and 2020, with a total potential value across the awards of $89,700. The contract has an ultimate completion date of September...

The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $16,265 purchase order to Capralogics Inc. for testing services. The firm fixed price contract will be performed in Hardwick, Massachusetts over a three-month period from July 1, 2023 through September 30, 2023. As the intramural research program of the NCI, a component of the NIH focused on cancer research, this contract supports the agency's mission to lead the nation's...

The National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), awarded a firm fixed-price purchase order contract to N-Of-One, Inc. for laboratory testing services. The contract, valued at $11,925.00, has an ultimate completion date of September 13, 2024. N-Of-One, Inc. is a self-certified small disadvantaged business that has received four prime federal contract awards from the NCI between 2019 and 2020, with a total potential value of...

This is a federal contract award to Laboratory Corporation of America (LabCorp), a major life sciences company, to provide non-invasive prenatal testing (NIPT) services. The contract, valued at $35,928, was issued by the National Human Genome Research Institute, a civilian agency, through the Medical Laboratory Testing and Analysis Services (FSS-621-II) schedule under the General Services Administration (GSA). The contract is a delivery order, with a firm fixed-price pricing type and an ultimate...

The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $25,000 purchase order to Nanostring Technologies, Inc. for testing services. The firm fixed price contract will be performed in Seattle, Washington over a four month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's biomedical research mission. No subcontractors or set aside designations...